OXYGENTA PHARMACEUTICAL
Back to All Ratios
|
OXYGENTA PHARMACEUTICAL Last 5 Year Return on Assets (ROA) History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROA(%) | -20.42 | -16.57 | -6.40 | -27.09 | -1.88 |
What is the latest Return on Assets (ROA) ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2026 | -20.42 |
| Mar2025 | -16.57 |
| Mar2024 | -6.40 |
| Mar2023 | -27.09 |
| Mar2022 | -1.88 |
How is Return on Assets (ROA) of OXYGENTA PHARMACEUTICAL Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2026 | -20.42 | Negative | |
| Mar2025 | -16.57 | Negative | |
| Mar2024 | -6.4 | Negative | |
| Mar2023 | -27.09 | Negative | |
| Mar2022 | -1.88 | - | |
Other Financial Ratios of OXYGENTA PHARMACEUTICAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.2 Cr | -3.9% | 5.2% | -55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.9% |
5.2% |
-55.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses